{"nctId":"NCT01617460","briefTitle":"A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder","startDateStruct":{"date":"2012-09"},"conditions":["Autistic Disorder"],"count":86,"armGroups":[{"label":"Aripiprazole","type":"EXPERIMENTAL","interventionNames":["Drug: Aripiprazole"]}],"interventions":[{"name":"Aripiprazole","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* The patient meets Autistic disorder diagnostic criteria defined in DSM-IV-TR.\n* The patient has completed the 031-11-002 study (the patient has visited the hospital during week8)\n* Inpatient or outpatient status\n\nExclusion Criteria:\n\n* The patient is currently diagnosed with another disorder on the autism spectrum in DSM-IV-TR, including Asperger's, Rett's Disorder, PDD-NOS, Childhood Disintegrative Disorder, or Fragile-X Syndrome.\n* Patients who fall under a contraindication listed in the ABILIFY package insert\n* Others","healthyVolunteers":false,"sex":"ALL","minimumAge":"6 Years","maximumAge":"17 Years","stdAges":["CHILD"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Mean Change From Baseline at the Final Assessment in Aberrant Behavior Checklist Japanese Version (ABC-J) Irritability Subscale Score","description":"The ABC-J Irritability subscale consists of 15 items. Each item scores range from 0 to 3: 0 = No problem, 1 = Mild aberrant behavior, 2 = Moderate aberrant behavior, and 3 = Severe aberrant behavior. Individual scores were summed, therefore, the overall score range was between 0-45. Higher scores represent worse condition.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.2","spread":"8.1"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":10,"n":86},"commonTop":["Nasopharyngitis","Somnolence","Influenza","Weight increased","Vomiting"]}}}